Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹4,422 Cr
down ₹142 Cr vs Dec 2022
- Stocks held
- 30
- 1 vs Dec 2022
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In January 2023 it disclosed 30 stocks worth ₹4,422 Cr, down ₹142 Cr from Dec 2022. Its largest positions were Sun Pharmaceutical Industries Limited (15.3%), Dr. Reddy's Laboratories Limited (8.3%), Lupin Limited (7.5%); the ten largest together made up 64.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.2% of its equity. Cash and debt stood at 0.7%. Compared with Dec 2022 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
90%
Top-10 weight is higher than 90% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
9%
Holds more cash than 9% of peers
Holdings in January 2023
Download CSVEvery line the fund disclosed, with the change against Dec 2022. Click a column to sort; click a company to see every fund that owns it.
| Sun Pharmaceutical Industries Limited | 15.34% | up 0.95 pts | ₹678 Cr | up ₹21.7 Cr | Added |
| Dr. Reddy's Laboratories Limited | 8.28% | up 0.07 pts | ₹366 Cr | down ₹8.8 Cr | Trimmed |
| Lupin Limited | 7.50% | up 0.27 pts | ₹332 Cr | up ₹1.6 Cr | Held |
| Cipla Limited | 6.91% | down 1.11 pts | ₹305 Cr | down ₹60.4 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 5.01% | down 0.10 pts | ₹222 Cr | down ₹11.5 Cr | Trimmed |
| Narayana Hrudayalaya Limited | 4.90% | down 0.07 pts | ₹217 Cr | down ₹10.2 Cr | Trimmed |
| Divi's Laboratories Limited | 4.87% | up 0.01 pts | ₹215 Cr | down ₹6.4 Cr | Trimmed |
| Abbott India Limited | 4.82% | down 1.23 pts | ₹213 Cr | down ₹63.1 Cr | Trimmed |
| Torrent Pharmaceuticals Limited | 3.79% | up 0.05 pts | ₹168 Cr | down ₹3.2 Cr | Trimmed |
| JB Chemicals & Pharmaceuticals Limited | 3.50% | up 0.27 pts | ₹155 Cr | up ₹7.5 Cr | Added |
| Zydus Lifesciences Limited | 3.37% | up 0.19 pts | ₹149 Cr | up ₹4 Cr | Added |
| Fortis Healthcare Limited | 3.30% | down 0.21 pts | ₹146 Cr | down ₹14.1 Cr | Trimmed |
| Aurobindo Pharma Limited | 3.23% | down 0.13 pts | ₹143 Cr | down ₹10.6 Cr | Trimmed |
| Gland Pharma Limited | 2.94% | up 0.87 pts | ₹130 Cr | up ₹35.5 Cr | Added |
| Sanofi India Limited | 2.77% | down 0.09 pts | ₹122 Cr | down ₹7.9 Cr | Trimmed |
| Ajanta Pharma Limited | 2.75% | up 0.08 pts | ₹122 Cr | down ₹22 L | Held |
| Vijaya Diagnostic Centre Limited | 2.62% | up 0.12 pts | ₹116 Cr | up ₹1.9 Cr | Added |
| Pfizer Limited | 2.57% | down 0.28 pts | ₹113 Cr | down ₹16.5 Cr | Trimmed |
| Thyrocare Technologies Limited | 2.23% | down 0.17 pts | ₹98.5 Cr | down ₹10.7 Cr | Trimmed |
| Alkem Laboratories Limited | 1.92% | up 0.06 pts | ₹85 Cr | up ₹19 L | Held |
| Indoco Remedies Limited | 1.36% | down 0.28 pts | ₹60.1 Cr | down ₹14.5 Cr | Trimmed |
| IPCA Laboratories Limited | 1.35% | up 0.05 pts | ₹59.6 Cr | up ₹47 L | Added |
| MedPlus Health Services Limited | 1.19% | up 0.82 pts | ₹52.8 Cr | up ₹35.7 Cr | Added |
| Orchid Pharma Limited | 0.78% | down 0.02 pts | ₹34.5 Cr | down ₹1.9 Cr | Trimmed |
| Cash, TREPS & receivables | 0.70% | up 0.26 pts | ₹31.1 Cr | up ₹10.7 Cr | Added |
| GlaxoSmithKline Pharmaceuticals Limited | 0.51% | down 0.01 pts | ₹22.4 Cr | down ₹1.3 Cr | Trimmed |
| Jubilant Pharmova Limited | 0.44% | down 0.01 pts | ₹19.4 Cr | down ₹1.3 Cr | Trimmed |
| Tarsons Products Limited | 0.35% | up 0.01 pts | ₹15.4 Cr | down ₹4 L | Held |
| Healthcare Global Enterprises Limited | 0.26% | up <0.01 pts | ₹11.4 Cr | down ₹14 L | Trimmed |
| Syngene International Limited | 0.23% | down <0.01 pts | ₹10.1 Cr | down ₹42 L | Trimmed |
| Global Health Limited | 0.20% | down <0.01 pts | ₹9 Cr | down ₹50 L | Trimmed |
What changed, Dec 2022 to Jan 2023
New New positions (0)
None.
Exited Exited (1)
- Rainbow Childrens Medicare Limitedwas 0.4% · ₹17.1 Cr
Added Biggest additions
- MedPlus Health Services Limitedup ₹35.7 Cr (+0.82% pts)
- Gland Pharma Limitedup ₹35.5 Cr (+0.87% pts)
- Sun Pharmaceutical Industries Limitedup ₹21.7 Cr (+0.95% pts)
- JB Chemicals & Pharmaceuticals Limitedup ₹7.5 Cr (+0.27% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2022, the weight rose most in Retailing (+0.8 pts) and Pharmaceuticals & Biotechnology (+0.2 pts), and fell most in Healthcare Services (−0.8 pts) and Pharmaceuticals (−0.3 pts).
- Retailing0.4% → 1.2%+0.8 pts
- Pharmaceuticals & Biotechnology78.0% → 78.2%+0.2 pts
- Healthcare Services19.6% → 18.9%−0.8 pts
- Pharmaceuticals1.6% → 1.4%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2020 | Jan 2022 | Jul 2022 | Oct 2022 | Dec 2022 | Jan 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.7% | 75.3% | 80.4% | 80.1% | 78.0% | 78.2% |
| Healthcare Services | 20.5% | 22.3% | 17.4% | 18.1% | 19.6% | 18.9% |
| Pharmaceuticals | 1.9% | 1.8% | 1.5% | 1.4% | 1.6% | 1.4% |
| Retailing | — | — | — | — | 0.4% | 1.2% |
| Healthcare Equipment & Supplies | — | 0.5% | 0.6% | 0.4% | 0.3% | 0.4% |
Allocation in Jan 2023change vs Dec 2022
- Pharmaceuticals & Biotechnology (19)78.2%▲ 0.2 pts
- Healthcare Services (8)18.9%▼ 0.8 pts
- Pharmaceuticals (1)1.4%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jan 2023
0.7%
▲ 0.3 pts vs Dec 2022
- Cash alone
- 0.7%
- cash and net receivables
- A year earlier
- 0.4%
- Jan 2022 · now ▲ 0.3 pts
- Last 12 months
- 0.3% – 2.2%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.